Reck M, De T, Paz-Ares L, Edmondson-Jones M, et al. Treatment-Switching Adjustment of Overall Survival in CheckMate 227 Part 1 Evaluating First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy for Metastatic Nonsmall Cell Lung Cancer. Clin Lung Cancer 2024 Jun 29:S1525-7304(24)00131.
PMID: 39097467